Table 1 from Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1–Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study
收藏数据链接：
官方服务：
资源简介：
Patient baseline characteristics (FAS).
创建时间：
2025-10-13
